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Abstract
Simian virus 40 (SV40) is an oncogenic DNA virus that induces malignant transformation. Endothelin (ET), a 21 amino
acid peptide with mitogenic and anti-apoptotic effects, binds to G-protein coupled ETA and ETB receptors. This report
examines the effect of SV40 transformation on the expression of ET receptors. Results from receptor binding and reverse
transcription (RT)-polymerase chain reaction (PCR) studies show that human lung fibroblasts IMR90 and WI38 express
both ETA and ETB receptors, and that the expression of both receptors is significantly down-regulated in IMR90-SV40 and
WI38-SV40, cell lines derived from IMR90 and WI38 with SV40 virus transformation. Receptor binding and RT-PCR
analysis of 3A(tPA-30-1), a cell line derived from human placenta that expresses a higher level of SV40 large T-antigen at the
permissive temperature (33‡C) than at the restrictive temperature (40‡C), further demonstrates that there is an inverse
correlation between the expression of SV40 T-antigen and the expression of ET receptor. ET-1 and fetal bovine serum
stimulate DNA synthesis in non-transformed cells ; however, proliferation of transformed cells is independent of either fetal
bovine serum or ET-1. We conclude that SV40 transformation down-regulates the expression of ET receptors, and that
expression of ET receptors is inversely correlated with expression of SV40 large T-antigen. ß 1999 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Endothelin (ET), originally isolated from cultured
porcine aortic endothelial cells, is a peptide with
21-amino acid residues [1]. Three distinct members
of the ET family, namely, ET-1, ET-2, and ET-3,
have been identi¢ed through cloning [2]. The e¡ects
of ETs on mammalian organs and cells are initiated
by their binding to G-protein coupled membrane re-
ceptors. Binding of ET to its receptor triggers a va-
riety of intracellular signaling. Two types of ET re-
ceptor (ETA and ETB) have been cloned and
characterized [3,4]. The ETA receptor is selective
for ET-1 and ET-2, whereas the ETB receptor binds
ET-1, ET-2, and ET-3 with similar a⁄nities.
ET-1 is thought to play important roles in various
pathophysiological conditions. ET is a mitogen for
many types of cells, including smooth muscle cells
[5^8] and cancer cells [9,10]. ET-1 is shown to acti-
vate protein kinase C (PKC), PI3P-kinase, and the
extracellular signal-related kinase (ERK) pathway
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[11]. More recently, it is shown that ET-1 also exhib-
its anti-apoptotic e¡ects [12,13]. Possibly ET-1 plays
an important role in promoting tumor growth
through an autocrine and/or paracrine mechanism
[14^16]. Simian virus 40 (SV40) has been identi¢ed
as an oncogenic DNA tumor virus that induces ma-
lignant transformation by regulating the expression
of growth-related genes [17]. Very little is known
about the e¡ect of SV40 infection on the ET system.
In this report, we examine the e¡ect of SV40 trans-
formation and large T-antigen expression on the ex-
pression of ET receptors.
2. Materials and methods
2.1. Materials
[125I]ET-1 (2200 Ci/mmol) and [3H]thymidine (20
Ci/mmole) were purchased from New England Nu-
clear (Boston, MA). ET-1 and ET-3 were from
American Peptide Company (Sunnyvale, CA). Re-
verse transcription (RT)-polymerase chain reaction
(PCR) primers were synthesized in house. All other
reagents were of analytical grade.
2.2. Cell cultures
IMR90 human ¢broblasts, IMR90-SV40, WI38
human ¢broblasts, and WI38-SV40 cells were pur-
chased from Coriell Cell Repositories (Camden,
NJ), and 3A(tPA-30-1) cells from American Type
Culture Collection (Rockville, MD). IMR90,
IMR90-SV40, WI38, and WI38-SV40 cells were
grown in modi¢ed Eagle’s medium (MEM) contain-
ing 20% fetal bovine serum (FBS); 3A(tPA-30-1)
cells were grown in alpha minimum essential medium
containing 10% FBS. All the cells were grown in
humidi¢ed cell culture incubators containing 5%
CO2 at 37‡C unless indicated otherwise.
2.3. RT-PCR
Total RNA was isolated from cells using TRIzol
Reagent (Gibco/BRL, Grand Island, NY). RT-PCR
was performed using a GeneAmp RNA PCR kit
(Perkin Elmer Cetus, Foster City, CA) according to
the manufacturer’s instructions. Brie£y, 1.0 Wg of
total RNA was reverse transcribed using random
hexamer primers. The cDNAs were then ampli¢ed
for 30 cycles using paired primers speci¢c for human
ETA, ETB, or glyceraldehyde-3-phosphate dehydro-
genase (GAPDH). Each cycle consisted of 94‡C for
1 min, 60‡C for 2 min, and 72‡C for 3 min. The
primer sets, based on the published sequences of
human ET receptors, were synthesized in house.
ETA : 5P-GATCACAATGACTTTGGCGTATTTC-
3P and 5P-CTCAAGCTGCCATTCCTTCTGTTC-3P.
ETB : 5P-CTAAAGGAGACAGGACGGCAGGAT-
C-3P and 5P-GATTCGCAGATAACTTCCTTTGT-
AG-3P. Human GAPDH was used as the control.
The RT-PCR samples were analyzed by standard
agarose gel electrophoresis.
2.4. [125I]ET-1 binding to cells
Cells in 48-well culture plates were incubated with
0.2 ml/well of binding bu¡er (140 mM NaCl, 5 mM
KCl, 1.8 mM CaCl2, 0.8 mM MgSO4, 5 mM glucose,
25 mM HEPES, 0.1% bovine serum albumin, 5 Wg/
ml pepstatin A, 0.1 mM phosphoramidon, 0.01 mM
phenylmethylsulfonyl £uoride (PMSF), and 0.025%
bacitracin, pH 7.4) containing [125I]ET-1 for 4 h at
4‡C. After the incubation, cells were washed twice
with 0.5 ml/well of phosphate-bu¡ered saline (PBS),
followed by solubilization with 0.2 ml of 0.1 N
NaOH. Non-speci¢c binding was determined in the
presence of 1 WM ET-1. Binding results were ana-
lyzed by the radioligand binding analysis program
‘EBDA and LIGAND’ (Biosoft, MO, USA) to cal-
culate Bmax and Kd values.
2.5. Western blot
Cells grown in 100 mm dishes were washed with
PBS followed by the addition of 0.6 ml of RIPA
bu¡er (1% NP-40, 0.5% sodium deoxycholate, and
0.1% SDS in PBS) containing 0.1 mg/ml PMSF,
30 Wl/ml aprotinin, and 1 mM sodium orthovana-
date. The cell lysates were collected and centrifuged
at 16 000Ug for 15 min at 4‡C. The supernatants
were collected. Samples (20 Wg/sample) were resolved
by SDS-PAGE using an 8^16% gradient gel (Novex,
San Diego, CA) and proteins were electrophoreti-
cally transferred to a PVDF membrane (Immobi-
lon-P, 0.45 Wm pore size, Millipore, Burlington,
BBAMCR 14463 21-4-99
W.J. Chiou et al. / Biochimica et Biophysica Acta 1450 (1999) 35^4436
Fig. 1. ET-1 binding studies in IMR90 cells. (A) IMR90 or (B) IMR90-SV40 cells in 48-well plates were incubated for 4 h at 4‡C
with increasing concentrations of [125I]ET-1 in the absence (a) or presence (R) of 1 WM unlabeled ET-1. Speci¢c binding (b) was de-
termined by subtraction of non-speci¢c binding (R) from total binding (a). Each value represents the mean þ S.D. of three determina-
tions. Inset: Scatchard analysis of the data.
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MA) for Western blotting. The membrane was blot-
ted with 5% non-fat dry milk (NFDM) in TBS-T
(10 mM Tris, pH 8.0, 0.15 M NaCl, 0.1% Tween
20) for 30 min, and then incubated with an anti-
SV40 T-antigen antibody derived from rabbit (Santa
Cruz Biotechnology, Santa Cruz, CA) in TBS-T con-
taining 5% NFDM for 1 h at 25‡C. The membrane
was washed with TBS-T and incubated with a horse-
Fig. 2. ET-1 binding studies in WI38 cells. (A) WI38 or (B) WI38-SV40 cells in 48-well plates were incubated for 4 h at 4‡C with in-
creasing concentrations of [125I]ET-1 in the absence (a) or presence (R) of 1 WM unlabeled ET-1. Speci¢c binding (b) was determined
by subtraction of non-speci¢c binding (R) from total binding (a). Each value represents the mean þ S.D. of three determinations. In-
set : Scatchard analysis of the data.
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radish peroxidase-labeled anti-rabbit antibody for 1 h
at 25‡C. The membrane was then incubated with
detection reagent containing luminol in an alkaline
bu¡er. The speci¢c bands were visualized by expos-
ing the membrane to blue light-sensitive autoradiog-
raphy ¢lms.
2.6. DNA synthesis
Cells in 48-well plates were cultured in growth me-
dium until at 80% con£uence. Cells were then cul-
tured in serum-free medium for 48 h at 37‡C, and
incubated with 0.4 ml/well medium containing 10%
FBS or 10 nM ET-1 in the presence of 1 WCi/well of
[3H]thymidine for another 20 h. After the incubation,
each well was washed with 1 ml of PBS, and then
treated with 0.5 ml of ice-cold 10% TCA for 30 min
at 4‡C. Each well was then washed again with 0.5 ml
of 10% TCA. Materials not soluble in TCA were
dissolved in 0.1 N NaOH for scintillation counting.
3. Results
To characterize ET receptors in IMR90 and
IMR90-SV40 cells, the number of ET binding sites
was determined in saturation binding studies. As
shown in Fig. 1A, ET-1 binding to IMR90 cells
reached a plateau when the free ET-1 concentration
in the bu¡er was 0.2 nM. The Scatchard plot (inset)
resulted in a straight line and yielded the values of
maximum binding (Bmax) and equilibrium dissocia-
tion constant (Kd) at 51 fmole/106 cells (or 30 700
sites/cell) and 0.063 nM, respectively. ET-1 satura-
tion binding in IMR90-SV40 cells (Fig. 1B) yielded
a much lower Bmax value at 0.82 fmole/106 cells (or
490 sites/cell) and a Kd value at 0.137 nM. The ET-1
binding sites in the SV40-transformed IMR90 cells
were less than 2% of those in the non-transformed
cells.
Similar results were obtained for WI38 and WI38-
SV40 cells. As shown in Fig. 2A, in saturation bind-
ing studies, ET-1 binding to WI38 cells reached a
plateau when the free ET-1 concentration in the bu¡-
er was 0.2 nM. The Scatchard plot (inset) resulted in
a straight line and yielded the values of maximum
binding (Bmax) and equilibrium dissociation constant
(Kd) at 55 fmole/106 cells (or 32 900 sites/cell) and
0.055 nM, respectively. ET-1 saturation binding in
WI38-SV40 cells (Fig. 2B) yielded a much lower
Bmax value at 0.27 fmole/106 cells (or 160 sites/cell)
and a Kd value at 0.04 nM. The ET-1 binding sites in
the WI38-SV40 cells were 0.5% of those in the non-
transformed cells. Please note that, because of the
substantially reduced binding sites in the transformed
cells, binding data for both IMR-SV40 and WI38-
SV40 cells appear to have larger standard deviation,
and seem to scatter more in the Scatchard plots (in-
set).
When the cell lysates prepared from the SV40-
transformed and non-transformed cells were ana-
lyzed by SDS-PAGE and Western blot for SV40
large T-antigen, the IMR90-SV40 and WI38-SV40
cells expressed a clearly detectable level of large
Fig. 3. T-antigen Western blot in IMR90 and WI38 cells. Cell
lysates (20 Wg/sample) were analyzed by SDS-PAGE and West-
ern blotting as described in Section 2. The molecular mass of
SV40 large T-antigen is 94 kDa.
Table 1
Summary of ET-1 binding characteristics and T-antigen levels
Cell types Kd
(nM)
Bmax
(sites/cell)
T-Antigen
expressiona
IMR90 0.063 30 700 0
IMR90-SV40 0.137 490 2 260
WI38 0.055 32 900 0
WI38-SV40 0.040 160 400
3A (40‡C) 0.52 20 000 340
3A (33‡C) 0.64 6 000 4 460
aWestern blot analysis of T-antigen expression is shown in
Figs. 3 and 5A. The level of T-antigen (arbitrary units) was de-
termined by a densitometer.
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T-antigen, whereas the non-transformed cells did not
express detectable T-antigen (Fig. 3). Fig. 3 also
shows that large T-antigen was present at a higher
level in IMR90-SV40 cells than in WI38-SV40
cells.
Results from the above binding studies and the
Western blot analysis are summarized in Table 1.
To examine the ET receptor mRNA levels in these
cells, we performed RT-PCR using human ETA and
ETB primers, and GAPDH as the control. As shown
in Fig. 4A, the ETA mRNAs in IMR90 and WI38
cells were expressed at higher levels than in IMR90-
SV40 and WI38-SV40 cells. A similar observation
was made for the ETB mRNAs. The GAPDH
mRNA levels were similar in parental vs. SV40-
transfected cells. Quantitative analysis of Fig. 4A
by a densitometer shows that the levels of ETA and
ETB mRNAs in the parental cells were 3^7-fold high-
er than the levels in SV40-transformed cells (Fig.
4B). These results are consistent with the binding
studies in that transformation of IMR90 and WI38
cells by SV40 virus down-regulated the expression of
both ETA and ETB receptors.
Further, to investigate the e¡ect of SV40 transfor-
mation on the expression of ET receptors, we studied
3A(tPA-30-1), a temperature-sensitive SV40 tsA30
virus-transformed human placenta cell line. These
cells express transformed phenotype at the permissive
temperature (33‡C) and non-transformed phenotype
at the restrictive temperature (40‡C). Fig. 5A shows
Fig. 4. Detection of ET receptor mRNA by RT-PCR in IMR90, IMR90-SV40, WI38, and WI38/SV40 cells. (A) Total RNA was iso-
lated from the cells, and RT-PCR was conducted as described in Section 2. Samples were analyzed by ethidium bromide stained 1.2%
agarose gel. The expected sizes of PCR products for ETA, ETB, and GAPDH are 427 bp, 547 bp and 950 bp, respectively. (B) Quan-
titative analysis of (A) by a densitometer.
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that the cells cultured at 33‡C for 4 days, when com-
pared to 40‡C, expressed a higher level (s 10-fold) of
large T-antigen. Results from densitometry analysis
of Fig. 5A are included in Table 1. Results from
binding studies (Fig. 5B) show that there were
more ET-1 binding sites in cells cultured at 40‡C.
The Bmax and Kd values were 20 000 sites/cells and
0.52 nM for cells at 40‡C vs. 6000 sites/cells and
0.64 nM for cells at 33‡C (Table 1). Consistent
with the binding results, Fig. 6A shows that the
ETA mRNA level in cells incubated at the permissive
temperature (33‡C) was signi¢cantly lower than that
in cells incubated at the restrictive temperature, while
the GAPDH mRNA levels were similar in cells in-
cubated at both temperatures. Quantitative analysis
of Fig. 6A shows that the level of ETA mRNA at
40‡C was 3.7-fold higher than that at 33‡C (Fig. 6B).
Interestingly, the 3A(tPA-30-1) cells do not express
ETB receptor. These results suggest that the expres-
sion of large T-antigen is inversely correlated with
that of ET receptor.
Finally, to investigate whether SV40 transforma-
tion a¡ects the growth state of IMR90 and WI38
cells, we examined DNA synthesis in these cells.
Fig. 7A shows that thymidine incorporation in
IMR90 cells cultured in serum-free medium was
8379 þ 1307 cpm/well. Addition of 10% FBS for
20 h stimulated thymidine incorporation by 420%.
ET-1 at 10 nM stimulated DNA synthesis by
340%. Our results show that ET-1 at 10 nM is almost
as potent as 10% FBS in stimulating DNA synthesis
in these cells. Although IMR90-SV40 cells were
plated at the same density as IMR90, thymidine in-
corporation in IMR90-SV40 cells cultured in serum-
free medium was 81 934 þ 3294 cpm/well, much high-
er than that in IMR90 cells (Fig. 7A). Addition of
either 10% FBS or 10 nM ET-1 failed to stimulate
DNA synthesis further. A similar observation was
made for WI38. Fig. 7B shows that, in the non-trans-
formed WI38 cells, thymidine incorporation in cells
cultured in serum-free medium was very low
(547 þ 100 cpm/well). Addition of 10% FBS for 20 h
stimulated thymidine incorporation to 466% of con-
trol. The e¡ect of ET-1 on stimulating DNA synthe-
sis in these cells was less profound than that of FBS
with 143% stimulation observed at 10 nM ET-1.
Thymidine incorporation in WI38-SV40 cells cul-
tured in serum-free medium was highly active
(185 500 þ 18 180 cpm/well). Addition of 10 nM ET-
1 had no e¡ect; cells cultured in the presence of 10%
FBS exhibited a slightly lower rate of DNA synthe-
sis. These results suggest that transformation of these
cells by SV40 not only results in the down-regulation
of ET receptors, but also results in an increase in
DNA synthesis, which is no longer regulated by se-
rum and/or ET-1.
4. Discussion
ET-1 plays important roles in various pathophys-
Fig. 5. T-antigen Western blot and ET-1 binding studies in
3A(tPA-30-1) cells. (A) Western blot. Cells were incubated at
the permissive temperature (33‡C) or restrictive temperature
(40‡C) for 4 days. Cell lysates (20 Wg/sample) were analyzed by
SDS-PAGE and Western blotting as described in Section 2.
The molecular mass of SV40 large T-antigen is 94 kDa. (B)
Binding studies. Cells cultured at 33‡C or 40‡C for 4 days were
incubated for 4 h at 4‡C with increasing concentrations of
[125I]ET-1 in the absence or presence of 1 WM unlabeled ET-1.
Data shown are speci¢c ET-1 binding, calculated by subtracting
the non-speci¢c binding from the total binding and normalized
by the number of cells. Each value represents the mean þ S.D.
of three determinations.
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iological conditions including cell growth disorders.
For example, Nelson et al. [9,18] have shown that
plasma ET-1 levels are elevated in advanced prostate
cancer patients, and that ET-1 may be associated
with the progression of metastatic prostate cancer.
ET-1 is present in various cell types within colorectal
liver metastases and the ET level is increased in the
plasma of patients with colorectal cancer [19]. It is of
primary interest to understand how the ET system is
regulated under di¡erent pathological conditions.
SV40 is one of the oncogenic DNA tumor viruses
that induce malignant transformation. We thus set
out to investigate whether SV40 transformation af-
fects the expression of ET receptors.
Our RT-PCR and receptor binding studies show
that the proteins and mRNAs of both ETA and ETB
are much less in IMR90-SV40 and WI38-SV40 than
in IMR90 and WI38 cells. Previously it has been
reported that the expression of ET receptors is
down-regulated in SV40-transformed WI38, as com-
pared to WI38 cells [20]. Our results con¢rm this
observation. However, the studies using IMR90
and WI38 cells alone did not give a conclusive an-
swer to the question of whether or not SV40 trans-
formation and T-antigen expression down-regulate
ET receptors. Although IMR90-SV40 and WI38-
SV40 were originally derived from IMR90 and
WI38 by SV40 infection, we could not rule out the
possibility that the observation of fewer ET receptors
in IMR90-SV40 and WI38-SV40 than in the parental
cells may be a coincidence.
The studies with the 3A(tPA-30-1) cells were hence
conducted to further investigate the above observa-
tion that SV40 transformation and T-antigen expres-
sion down-regulate ET receptors. 3A(tPA-30-1) is a
human placental cell line that harbors a temperature-
sensitive mutant SV40 tsA30 [21]. Our result from
the Western blot analysis con¢rms that 3A(tPA-30-
1) cells express a higher level of SV40 large T-antigen
at the permissive temperature (33‡C) than at the re-
strictive temperature (40‡C). Using the same cell line
with or without the expression of T-antigen, our re-
sults clearly demonstrate that there is an inverse cor-
relation between the expression of large T-antigen,
and the expression of ET receptors.
It has been reported that SV40 transformation and
the resulting expression of SV40 T-antigen have var-
ious e¡ects on cells, including modulation of gene
expressions, and alteration in signal transduction
pathways [22]. At present, the mechanism by which
SV40 transformation a¡ects the expression of ET
receptors is not clear. It is obvious from our studies
that not only the proteins, but also the mRNAs of
ET receptors are down-regulated in SV40 trans-
formed cells. Therefore, we suspect that, if SV40
transformation does regulate the expression of ET
receptors, the regulation is at the transcriptional lev-
el. Do the SV40 proteins such as the large T-antigen
Fig. 6. Detection of ET receptor mRNA by RT-PCR in 3A(tPA-30-1) cells. (A) Total RNA was isolated from cells incubated at 40‡C
or 33‡C for 4 days. RT-PCR was conducted as described in Fig. 4. (B) Quantitative analysis of (A) by a densitometer.
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directly interact with the ET receptor promoter re-
gions? Or, do the SV40 proteins interfere with the
signaling pathways which are required for the expres-
sion of the ET receptors? These are questions yet to
be answered.
Consistent with the notion that ET-1 is a mitogen,
and a survival factor for various cells [5^10,12,13],
our results show that ET-1 at 10 nM stimulates
DNA synthesis in IMR90 and WI38 cells, although
the e¡ect of ET-1 on WI38 cell proliferation is less
profound. It is known that SV40 is able to transform
cells to a new state in which the growth of cells is no
longer dependent on mitogens and survival factors.
Indeed, our results show that, although ET-1 or FBS
is required for the growth of IMR90 cells, the trans-
formation of these cells by SV40 results in serum or
ET-1 independent cell growth. Regarding WI38 cells,
the growth of WI38 is dependent on FBS, and ET-1
exhibits a modest e¡ect in stimulating DNA synthe-
sis in these cells. However, similar to the IMR90
cells, SV40-transformed WI38 cells continue to pro-
liferate in the absence of either ET-1 or FBS. From
these results, it is possible that there is a link between
the down-regulation of ET receptor expression by
SV40 transformation and the continuing prolifera-
tion of these cells in the absence of ET-1. However,
more studies will be needed to understand the phys-
iological or pathological signi¢cance of the observa-
tion.
In summary, we show that SV40 transformation
down-regulates the expression of both ETA and
ETB receptors. It appears that the expression of
SV40 T-antigen is inversely correlated with the ex-
pression of ET receptors.
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